The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-Allyl-1-(3-hydroxy-3-methyl-2,3-dihydrofuro[3,2-b]pyridin-5-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one ID: ALA4861168
PubChem CID: 139482624
Max Phase: Preclinical
Molecular Formula: C27H30N8O3
Molecular Weight: 514.59
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1ccc2c(n1)[C@@](C)(O)CO2
Standard InChI: InChI=1S/C27H30N8O3/c1-4-11-34-25(36)20-16-28-26(29-18-5-7-19(8-6-18)33-14-12-32(3)13-15-33)31-24(20)35(34)22-10-9-21-23(30-22)27(2,37)17-38-21/h4-10,16,37H,1,11-15,17H2,2-3H3,(H,28,29,31)/t27-/m0/s1
Standard InChI Key: PURQKJCVFGGRBZ-MHZLTWQESA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
11.2551 -15.0276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8447 -14.3228 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4385 -15.0359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1566 -10.6500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1566 -11.4748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8691 -11.8853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5817 -11.4748 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5817 -10.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8691 -10.2353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4404 -10.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2961 -11.8863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2917 -12.7154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0053 -13.1267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7219 -12.7174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7204 -11.8881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0063 -11.4763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4368 -13.1278 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1478 -12.7176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8595 -13.1292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8546 -11.4793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1430 -11.8955 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5747 -11.8939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5753 -12.7194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3609 -12.9727 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8474 -12.3035 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3598 -11.6352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6129 -10.8502 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6724 -12.3028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0822 -11.5874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9072 -11.5867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6152 -13.7541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0646 -14.3685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3183 -15.1525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4193 -13.9221 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6800 -14.7036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1287 -15.3225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5509 -16.0380 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3608 -15.8615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 2 1 1
1 3 1 0
4 5 1 0
4 9 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
4 10 1 0
7 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
14 17 1 0
17 18 1 0
18 19 2 0
19 23 1 0
22 20 1 0
20 21 2 0
21 18 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 26 1 0
26 22 1 0
26 27 2 0
25 28 1 0
28 29 1 0
29 30 2 0
31 32 2 0
32 33 1 0
33 36 2 0
35 34 2 0
34 31 1 0
24 31 1 0
35 36 1 0
36 37 1 0
37 38 1 0
38 3 1 0
3 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 514.59Molecular Weight (Monoisotopic): 514.2441AlogP: 2.26#Rotatable Bonds: 6Polar Surface Area: 113.57Molecular Species: NEUTRALHBA: 11HBD: 2#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.68CX Basic pKa: 7.96CX LogP: 2.40CX LogD: 1.74Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.37Np Likeness Score: -0.91
References 1. Huang PQ, Boren BC, Hegde SG, Liu H, Unni AK, Abraham S, Hopkins CD, Paliwal S, Samatar AA, Li J, Bunker KD.. (2021) Discovery of ZN-c3, a Highly Potent and Selective Wee1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of Cancer., 64 (17.0): [PMID:34423975 ] [10.1021/acs.jmedchem.1c01121 ]